On Demand Webinars

Get Over It: Embrace Payer Expectations by Introducing Them Early in Product Development
May 02, 2012
Slides
Forecasting Market Size and Burden of Illness Using Individual-Level Simulations
December 13, 2011
Slides Recording
Assessing Cognitive Function in Clinical Trials
December 07, 2011
Slides Recording
Multi-Faceted Registries: Not Your Typical Safety or Pregnancy Exposure Registry
November 30, 2011
Slides Recording
Regulatory Considerations for Non-Interventional Studies - Europe
November 03, 2011
Slides Recording
Part 3, Pharmacovigilance Webinar Series - Closing the Gap between Safety Signaling and Confirmatory Studies
November 02, 2011
Slides
Part 2, Pharmacovigilance Webinar Series - Pharmacovigilance for Co-marketed Products: Identifying and Overcoming Potential obstacles
October 26, 2011
Slides
Part 1, Pharmacovigilance Webinars Series - Out with the Old, In with the New: Operational Implications for the New European Pharmacovigilance Legislation
October 19, 2011
Slides
Innovative Technologies to Improve Data Quality in CNS Clinical Trials
October 12, 2011
Slides Recording
Patient Reported Outcome (PRO) Assessments in Clinical Trials: Navigating the EMA and FDA Regulatory Framework
September 22, 2011
Slides Recording
Why Nursing Services Improve Patient Adherence and Compliance
July 21, 2011
Slides Recording
Multi-National Retrospective Chart Review Studies
July 19, 2011
Slides Recording
Biometrics: Improve Quality with Cross-Functional Collaboration
June 29, 2011
Slides Recording
Operational Management of Non Interventional Studies (NIS) – A Project Manager's Perspective
June 07, 2011
Slides Recording
The Importance of Cognitive Function Testing in Global Drug Development
May 11, 2011
Slides Recording
Improve the Grade of Your REMS Communications: Increase Patient and HCP Comprehension
May 04, 2011
Slides Recording
Observational Research: Not Just for Safety Anymore!
April 21, 2011
Slides Recording
De-Risk Your Initial IND to Avoid a Clinical Hold
April 21, 2011
Slides Recording
Connecting with Patients in a Post-Marketing Environment through Mobile Technologies and Social Media
February 17, 2011
Slides Recording
How Risk Evaluation and Mitigation Strategies (REMS), Reimbursement and Distribution Initiatives Intersect to Minimize Risk, Optimize Access and Support Product Commercialization
October 27, 2010
Slides
The Costs of Autism in the United States
July 16, 2010
Recording
Risk-benefit models for pharmaceuticals and predicting the net impact of harm reduction strategies: How modeling can aid in evaluating the risks and benefits of medical treatments
March 02, 2010
Slides Recording
Patient-Reported Outcomes (PROs): Overview of the Final FDA Guidance Document
February 23, 2010
Slides